Oruka Therapeutics, Inc. reports

Company location: Menlo Park, CA
Fiscal year end: 31 December

Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 601-625 of 936 matching filings.

Per page

25

Current page

25

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 17 Jun 2015
Reporting date: 16 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 000-22873

CT ORDER filing

Filing date: 15 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-187508

424B4

Filing date: 11 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 000-22873

8-K/A

Filing date: 11 Jun 2015
Reporting date: 10 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-22873

DEFA14A

Filing date: 11 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-187508

424B4

Filing date: 11 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-22873

8-K

Filing date: 11 Jun 2015
Reporting date: 10 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-187508

424B4

Filing date: 05 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-22873

8-K

Filing date: 05 Jun 2015
Reporting date: 04 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 000-22873

CT ORDER filing

Filing date: 20 May 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-187508

424B4

Filing date: 12 May 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-22873

10-Q

Filing date: 12 May 2015
Reporting date: 31 Mar 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CT ORDER File 000-22873

CT ORDER filing

Filing date: 22 Apr 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .